Menu

• Ask a Health Expert about LEUKAEMIA RECURRENT
• Post Your Side Effect related to LEUKAEMIA RECURRENT
• LEUKAEMIA RECURRENT and FDA Warnings
• LEUKAEMIA RECURRENT in Patients Wiki
• Report LEUKAEMIA RECURRENT in Drug Side Effect Survey

LEUKAEMIA RECURRENT side effect

What is LEUKAEMIA RECURRENT ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Byetta Side Effects Report #5537582-2
Consumer or non-health professional from UNITED STATES reported BYETTA problem on Dec 01, 2007. Male patient, weighting 184.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: leukaemia recurrent, . BYETTA dosage: unknown. During the same period patient was treated with AMARYL, GLUCOPHAGE, INSULIN, ACTOS. Patient recovered.

Dexamethasone Side Effects Report #5574025-7
DEXAMETHASONE problem was reported by a Consumer or non-health professional from GERMANY on Nov 02, 2007. Male patient, 26 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with DEXAMETHASONE. After drug was administered, patient experienced the following problems/side effects: leukaemia recurrent, lymphopenia, neutropenia, systemic candida, . DEXAMETHASONE dosage: unknown. During the same period patient was treated with VINCRISTINE, DAUNORUBICIN, PEGASPARGASE, CYCLOPHOSPHAMIDE, CYTARABINE, MERCAPTOPURINE, METHOTREXATE, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Vincristine Side Effects Report #5528178-7
Consumer or non-health professional from GERMANY reported VINCRISTINE problem on Nov 07, 2007. Male patient, 26 years of age, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: leukaemia recurrent, lymphopenia, neutropenia, sinusitis, stem cell transplant, systemic candida, . VINCRISTINE dosage: unknown. During the same period patient was treated with METHOTREXATE, ETOPOSIDE, FLUDARABINE PHOSPHATE, DEXAMETHASONE, DAUNORUBICIN, PEGASPARGASE, CYCLOPHOSPHAMIDE, CYTARABINE. Patient was hospitalized. Patient recovered.

Byetta Side Effects Report #5502248-1
BYETTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 21, 2007. Male patient, weighting 187.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: leukaemia recurrent, weight increased, . BYETTA dosage: unknown. During the same period patient was treated with AMARYL, GLUCOPHAGE, INSULIN. Patient recovered.


Norditropin Side Effects Report #5411806-4
Physician from SWEDEN reported NORDITROPIN problem on May 21, 2007. Female patient, 21 years of age, weighting 105.8 lb, was treated with NORDITROPIN. After drug was administered, patient experienced the following problems/side effects: leukaemia recurrent, . NORDITROPIN dosage: unknown. During the same period patient was treated with GROWTROPIN II, EVOREL. Patient was hospitalized and became disabled. Patient recovered.

Forteo Side Effects Report #5376894-2
FORTEO problem was reported by a Physician from FRANCE on June 19, 2007. Female patient, 63 years of age, was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: leukaemia recurrent, . FORTEO dosage: unknown. Patient recovered.

Forteo Side Effects Report #5376894-2
Physician from FRANCE reported FORTEO problem on June 19, 2007. Female patient, 63 years of age, was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: leukaemia recurrent, . FORTEO dosage: unknown. Patient recovered.

Busulfex Side Effects Report #5767298-9
BUSULFEX problem was reported by a Consumer or non-health professional from FRANCE on May 27, 2008. Female patient, 44 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: leukaemia recurrent, thrombotic microangiopathy, . BUSULFEX dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, METHOTREXATE. Patient died.

Norditropin Side Effects Report #5344407-7
Physician from SWEDEN reported NORDITROPIN SIMPLEXX problem on May 21, 2007. Female patient, 21 years of age, weighting 105.8 lb, was treated with NORDITROPIN SIMPLEXX. After drug was administered, patient experienced the following problems/side effects: leukaemia recurrent, . NORDITROPIN SIMPLEXX dosage: unknown. During the same period patient was treated with GROWTROPIN II, EVOREL. Patient was hospitalized and became disabled. Patient recovered.


Cyclosporine Side Effects Report #5264703-1
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on Mar 05, 2007. Female patient, 58 years of age, was diagnosed with stem cell transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: leukaemia recurrent, pulmonary tuberculosis, respiratory failure, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, IRRADIATION. Patient died.

Keppra Side Effects Report #5605848-3
Physician from FRANCE reported KEPPRA problem on Jan 07, 2008. Male patient, child 10 years of age, was diagnosed with partial seizures and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, leukaemia recurrent, . KEPPRA dosage: unknown. During the same period patient was treated with TEGRETOL. Patient recovered.

Clolar Side Effects Report #5549623-7
CLOLAR problem was reported by a Physician from UNITED STATES on July 03, 2007. Male patient, child 12 years of age, weighting 69.23 lb, was diagnosed with acute lymphocytic leukaemia, leukaemia recurrent and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: klebsiella infection, leukaemia recurrent, platelet count abnormal, sepsis, white blood cell count abnormal, . CLOLAR dosage: 40 MG/M2 DAILY IV. During the same period patient was treated with CYTARABINE, PREDNISONE, ZOFRAN, PENTAMIDINE ISETHIONATE. Patient was hospitalized. Patient recovered.

Noxafil Side Effects Report #5477387-4
Physician from GERMANY reported NOXAFIL problem on Sept 21, 2007. Male patient was diagnosed with prophylaxis and was treated with NOXAFIL. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, leukaemia recurrent, . NOXAFIL dosage: 10 ML;BID;PO. Patient recovered.

Cancidas Side Effects Report #5453204-3
CANCIDAS problem was reported by a Physician from AUSTRALIA on Sept 06, 2007. Male patient, 63 years of age, was diagnosed with antifungal prophylaxis, immunosuppression and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: klebsiella sepsis, leukaemia recurrent, retinitis, . CANCIDAS dosage: unknown. During the same period patient was treated with PREDNISOLONE, MYCOPHENOLATE MOFETIL, VORICONAZOLE, TERBINAFINE. Patient died.


Cancidas Side Effects Report #5761299-2
Physician from AUSTRALIA reported CANCIDAS problem on May 23, 2008. Male patient, 63 years of age, was diagnosed with antifungal prophylaxis, immunosuppression and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: klebsiella sepsis, leukaemia recurrent, retinitis, vision blurred, . CANCIDAS dosage: unknown. During the same period patient was treated with PREDNISOLONE, MYCOPHENOLATE MOFETIL, VORICONAZOLE, TERBINAFINE. Patient died.

Elspar Side Effects Report #5764173-0
ELSPAR problem was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2008. Male patient, child 4 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, leukaemia recurrent, mucosal inflammation, pulmonary veno-occlusive disease, venoocclusive liver disease, . ELSPAR dosage: unknown. During the same period patient was treated with VINCRISTINE, PREDNISONE, METHOTREXATE, TENEPOSIDE, CYTARABINE. Patient was hospitalized. Patient recovered.

Cancidas Side Effects Report #5772120-0
Health Professional from AUSTRALIA reported CANCIDAS problem on May 29, 2008. Male patient, 63 years of age, was diagnosed with antifungal prophylaxis, immunosuppression and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: klebsiella sepsis, leukaemia recurrent, retinitis, vision blurred, . CANCIDAS dosage: unknown. During the same period patient was treated with PREDNISOLONE, MYCOPHENOLATE MOFETIL, VORICONAZOLE, TERBINAFINE. Patient died.

Etoposide Side Effects Report #5797753-7
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on June 19, 2008. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, leukaemia recurrent, myelodysplastic syndrome, . ETOPOSIDE dosage: 100 MG/M**2; DAILY;. During the same period patient was treated with MITOXANTRONE, CYTARABINE, DAUNORUBICIN, MELPHALAN. Patient died.

Busulfex Side Effects Report #5798834-4
Health Professional from JAPAN reported BUSULFEX problem on June 16, 2008. Female patient, 45 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: anorexia, leukaemia recurrent, leukocytosis, malaise, nausea, oral disorder, . BUSULFEX dosage: 5.3 ML INTRAVENOUS; 21.2 ML, DAILY DOSE; INTRAVENOUS; 15.9 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient died on 04/14/2007.


Carboplatin Side Effects Report #5711110-0
CARBOPLATIN problem was reported by a Physician from JAPAN on Apr 02, 2008. Male patient was diagnosed with hepatoblastoma and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, leukaemia recurrent, stem cell transplant, . CARBOPLATIN dosage: unknown. During the same period patient was treated with CISPLATIN, PIRARUBICIN. Patient died.

Revlimid Side Effects Report #5328102-6
Physician from UNITED STATES reported REVLIMID problem on May 08, 2007. Male patient, 73 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, leukaemia recurrent, myelodysplastic syndrome, pneumonia, pulmonary embolism, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 04/06/2007.

Methotrexate Side Effects Report #5286154-6
METHOTREXATE problem was reported by a Health Professional from AUSTRALIA on Apr 02, 2007. Female patient, 26 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: atrophy, leukaemia recurrent, malignant neoplasm progression, myelopathy, osteomyelitis, sepsis, spinal cord disorder, . METHOTREXATE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, DOXORUBICIN, DEXAMETHASONE, CYTARABINE, MERCAPTOPURINE. Patient died.

Methotrexate Side Effects Report #5293624-3
Consumer or non-health professional from reported METHOTREXATE problem on Apr 05, 2007. Female patient, 26 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: incontinence, leukaemia recurrent, myelopathy, osteomyelitis, paralysis flaccid, sensory loss, sepsis, . METHOTREXATE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DEXAMETHASONE, MERCAPTOPURINE, VINCRISTINE, DOXORUBICIN, CYTARABINE, ANTIVIRAL TREATMENT, STEROID TREATMENT. Patient died.

Revlimid Side Effects Report #5309179-0
REVLIMID problem was reported by a Physician from UNITED STATES on Apr 16, 2007. Male patient, 73 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute leukaemia, leukaemia recurrent, pneumonia, pulmonary embolism, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died.

Prograf Side Effects Report #5688149-7
Physician from JAPAN reported PROGRAF problem on Mar 17, 2008. Male patient, 17 years of age, was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, leukaemia recurrent, . PROGRAF dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS. Patient died on 04/01/2005.

Cancidas Side Effects Report #5622095-X
CANCIDAS problem was reported by a Physician from BELGIUM on Jan 21, 2008. Male patient, 69 years of age, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: klebsiella infection, leukaemia recurrent, staphylococcal bacteraemia, . CANCIDAS dosage: 70 MG/1X, IV; 50 MG/DAILY, IV. During the same period patient was treated with CONTRAMAL, CORUNO, TAVANIC, TAZOCIN, VFEND, XANAX, ZOVIRAX. Patient was hospitalized. Patient died.

Cyclophosphamide Side Effects Report #5625537-9
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Feb 11, 2008. Male patient, weighting 166.7 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, fluid overload, leukaemia recurrent, renal failure acute, respiratory distress, sepsis, . CYCLOPHOSPHAMIDE dosage: 9000 MG. During the same period patient was treated with METHOTREXATE, RAPAMYCIN, TACROLIMUS, THIOTEPA. Patient was hospitalized. Patient recovered.

Fortaz Side Effects Report #5639926-X
FORTAZ problem was reported by a Consumer or non-health professional from FRANCE on Feb 11, 2008. Male patient, 21 years of age, was diagnosed with acute myeloid leukaemia and was treated with FORTAZ. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased, leukaemia recurrent, pancreatitis acute, . FORTAZ dosage: unknown. During the same period patient was treated with ZOFRAN, CYTARABINE, MITOXANTRONE, CIFLOXECTION, URATE OXIDASEECTION, GEMTUZUMAB OZOGAMICINECTION, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Methotrexate Side Effects Report #5598690-3
Physician from GERMANY reported METHOTREXATE problem on Jan 08, 2008. Female patient, child 10 years of age, was diagnosed with prophylaxis against graft versus host disease, bone marrow conditioning regimen and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in skin, epstein-barr virus infection, leukaemia recurrent, mucosal inflammation, pericardial effusion, pulmonary oedema, renal failure, . METHOTREXATE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYCLOSPORINE. Patient recovered.

Cyclosporine Side Effects Report #5487701-1
CYCLOSPORINE problem was reported by a Health Professional from UNITED STATES on Oct 10, 2007. Male patient, 14 years of age, was diagnosed with stem cell transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: buccal polyp, graft versus host disease, leukaemia recurrent, mass excision, polypectomy, tongue disorder, . CYCLOSPORINE dosage: 7 MG/KG/D. During the same period patient was treated with METHOTREXATE, LORAZEPAM, ONDANSETRON, MAGNESIUM SULPHATE, PENTAMIDINE ISETHIONATE. Patient died.

Cyclophosphamide Side Effects Report #5458642-0
Health Professional from FRANCE reported CYCLOPHOSPHAMIDE problem on Sept 17, 2007. Male patient, 68 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: b-cell lymphoma, histiocytosis haematophagic, leukaemia recurrent, parvovirus infection, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CAMPATH, IMMUNE GLOBULIN. Patient recovered.

Cyclophosphamide Side Effects Report #5465800-8
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from FRANCE on Sept 21, 2007. Male patient, 68 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: b-cell lymphoma, histiocytosis haematophagic, leukaemia recurrent, parvovirus infection, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CAMPATH, IMMUNE GLOBULIN. Patient recovered.

Byetta Side Effects Report #5708400-4
Physician from UNITED STATES reported BYETTA problem on Apr 10, 2008. Female patient, weighting 216.1 lb, was diagnosed with diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: diabetic ketoacidosis, graft versus host disease, leukaemia recurrent, pancreatitis acute, . BYETTA dosage: unknown. During the same period patient was treated with METFORMIN, DEXAMETHASONE. Patient was hospitalized. Patient died on 04/09/2008.

Cyclosporine Side Effects Report #5362212-2
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on June 13, 2007. Male patient, 35 years of age, was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in skin, cryptogenic organising pneumonia, leukaemia recurrent, po2 decreased, pyrexia, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with METHOTREXATE, ENDOXAN, CYLOCIDE, FILGRASTIM. Patient died.

Cyclosporine Side Effects Report #5292108-6
Physician from CANADA reported CYCLOSPORINE problem on Mar 22, 2007. Female patient, 15 years of age, was diagnosed with prophylaxis and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: benign intracranial hypertension, csf pressure increased, leukaemia recurrent, papilloedema, retinal haemorrhage, vision blurred, . CYCLOSPORINE dosage: 1.5 MG/KG. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE. Patient recovered.

Novantrone Side Effects Report #5255844-3
NOVANTRONE problem was reported by a Consumer or non-health professional from JAPAN on Feb 14, 2007. Female patient, 83 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, febrile neutropenia, leukaemia recurrent, . NOVANTRONE dosage: 6 MG, 1 IN 1 DAYS, INTRAVENOUS. During the same period patient was treated with MYLOTARG, CYTARABINE, FLUDARABINE PHOSPHATE, FLUCONAZOLE, AMPHOTERICIN B, LEVOFLOXACIN, ITRACONAZOLE. Patient recovered.

Voriconazole Side Effects Report #5260768-1
Health Professional from UNITED STATES reported VORICONAZOLE problem on Feb 27, 2007. Female patient, 62 years of age, was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, blood alkaline phosphatase increased, leukaemia recurrent, nausea, vomiting, . VORICONAZOLE dosage: unknown. During the same period patient was treated with CANCIDAS, AMPHOTERICIN B. Patient died.